Nov 28, 2025 06:37AM
Oct 17, 2025 08:30AM
Oct 17, 2025 08:30AM
Aug 20, 2025 06:40AM
Aug 19, 2025 08:20AM
Aug 19, 2025 08:19AM
Jul 15, 2025 07:16AM H.C. Wainwright Reiterates Buy Rating on BiomX (PHGE)
Jul 14, 2025 09:01AM
Jul 14, 2025 09:00AM
May 19, 2025 10:02AM
May 16, 2025 06:45AM
Apr 4, 2025 06:44AM
Mar 31, 2025 06:31AM
Mar 31, 2025 06:30AM BiomX Announces Positive Topline Results from Phase 2 Trial Evaluating BX211 for the Treatment of Diabetic Foot Osteomyelitis (DFO)
Nov 15, 2024 07:28AM
Aug 15, 2024 06:30AM
Jul 10, 2024 06:31AM
Jul 10, 2024 06:30AM
May 30, 2024 07:05AM
May 30, 2024 07:00AM
May 21, 2024 06:30AM BiomX Reports First Quarter 2024 Financial Results and Provides Business and Program Updates
Apr 23, 2024 08:00AM
Apr 3, 2024 06:30AM
Mar 18, 2024 06:30AM
Mar 6, 2024 07:30AM
Mar 6, 2024 07:30AM
Jan 4, 2024 08:00AM
Nov 30, 2023 04:15PM BiomX to Host Virtual Key Opinion Leader (KOL) Event to Review the Positive Results from Part 2 of Phase 1b/2a Trial of BX004 in Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Infections
Nov 29, 2023 06:30AM
Nov 14, 2023 06:30AM
Oct 27, 2023 08:00AM
Oct 4, 2023 06:34AM
Sep 7, 2023 09:00AM
Aug 9, 2023 06:30AM
May 31, 2023 03:00AM BiomX to Present Part 1 Data from Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis During Late-Breaking Scie
Feb 22, 2023 06:30AM
Feb 22, 2023 06:30AM
Aug 10, 2022 06:30AM
Jun 27, 2022 06:30AM
May 6, 2022 07:00AM
Jan 4, 2022 07:10AM
Jan 4, 2022 07:00AM BiomX Announces Therapeutics Development Award of up to $5 Million from the Cystic Fibrosis Foundation
Nov 15, 2021 06:00AM
Mar 31, 2021 06:30AM
Feb 2, 2021 06:38AM
Feb 2, 2021 06:30AM
Nov 12, 2020 06:30AM
Nov 4, 2020 06:36AM
Nov 4, 2020 06:30AM BiomX Announces Dosing of First Subject in Phase 1a Study of BX002 Phage Therapy for Inflammatory Bowel Disease
Mar 26, 2020 06:30AM

322,094 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All